MAP2K7 and melanoma: However, prolonged exposure to trametinib led to the emergence of drug‐resistant melanoma subpopulations characterized by a transient increase in CD271 expression, the inhibition of which resulted in increased trametinib‐induced cell death, indicating that CD271 functions as a prosurvival mechanism in response to MEK inhibition.